Treatment of chronic constipation with cisapride and placebo
about
Cisapride for Intestinal ConstipationThe 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivoPrucalopride for constipation.Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersObstructed defecation.Serotonergic modulating drugs for functional gastrointestinal diseases.The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties.Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation.Role of serotonin in the pathophysiology of the irritable bowel syndrome.Cisapride in chronic idiopathic constipation: clinical response and effect on colonic transit time.The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.Acute colonic pseudo-obstruction: a pharmacological approach.Cisapride: what can we learn from the rise and fall of a prokinetic?5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders.Cisapride: a gastrointestinal prokinetic drug.Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation.Cisapride for the treatment of chronic idiopathic constipation.Treating constipation in the patient with diabetes.The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.Oral domperidone has no additional effect on chronic functional constipation in children: a randomized clinical trial.
P2860
Q24234695-91946EDB-B139-4083-8C4B-708290AA912AQ24671423-D7ED89E4-69F2-4183-93DD-AAB172278924Q34094831-CED6F8BA-E064-434E-966A-5D1B91D96EE6Q34166903-4963BFE5-5A08-4B98-825B-F43FF306E24BQ34354663-E3B720E1-A439-4E53-B436-3FD237372CF0Q34722737-425E2307-76CA-4B43-BA5F-21D2A7D38849Q35025872-6998F4FF-8D10-471C-B4B6-B1CB44B650ADQ35026383-C4F3753A-4672-4ECC-87F7-1E5C1ADACE38Q35047066-AE4BE7A0-206B-451C-8522-96729840BA89Q35938771-C95DB6AA-01DC-4CF6-AE24-05451448C85BQ36407290-38DD0295-383B-476E-8B31-42E0D2307042Q36813897-119A8D79-E078-4074-A24D-F132F46EB000Q37880285-80647E93-A7EC-497C-80EC-DF10513C7D6EQ37953385-A9F2E09B-47BA-4D35-A382-A338B66A7ABCQ38570021-5915F79D-5B81-4029-8136-488DB9B7D1FFQ39414529-BE01286A-26CE-4247-AA5A-8FA165818733Q40952963-082AC374-B6B7-44D0-9137-698DC4DAEBB0Q43326737-B2392A9D-A2BF-4F06-88E2-D6424A81B414Q43366415-C5A0BD66-1B21-49E4-B5BC-A5CBEC9606ABQ44315944-9D59C122-A8E1-42AE-A3CA-DEEA821525CD
P2860
Treatment of chronic constipation with cisapride and placebo
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Treatment of chronic constipation with cisapride and placebo
@ast
Treatment of chronic constipation with cisapride and placebo
@en
Treatment of chronic constipation with cisapride and placebo
@nl
type
label
Treatment of chronic constipation with cisapride and placebo
@ast
Treatment of chronic constipation with cisapride and placebo
@en
Treatment of chronic constipation with cisapride and placebo
@nl
prefLabel
Treatment of chronic constipation with cisapride and placebo
@ast
Treatment of chronic constipation with cisapride and placebo
@en
Treatment of chronic constipation with cisapride and placebo
@nl
P2860
P356
P1433
P1476
Treatment of chronic constipation with cisapride and placebo
@en
P2093
Müller-Lissner SA
P2860
P304
P356
10.1136/GUT.28.8.1033
P407
P577
1987-08-01T00:00:00Z